• Publications
  • Influence
Identification of the Fanconi Anemia Complementation Group I Gene, FANCI
To identify the gene underlying Fanconi anemia (FA) complementation group I we studied informative FA-I families by a genome-wide linkage analysis, which resulted in 4 candidate regions togetherExpand
  • 137
  • 10
  • PDF
Childhood leukaemia in Europe after Chernobyl: 5 year follow-up.
The European Childhood Leukaemia - Lymphoma Incidence Study (ECLIS) is designed to address concerns about a possible increase in the risk of cancer in Europe following the nuclear accident inExpand
  • 160
  • 5
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene
Fanconi anaemia (FA) is a genetically heterogeneous autosomal recessive disorder associated with chromosomal fragility, bone-marrow failure, congenital abnormalities and cancer. The gene forExpand
  • 96
  • 4
Psychosocial problems in families of a child with cancer.
Eighty-one children with malignancies and their families were investigated for the psychosocial changes that take place during the course of the disease. Seventeen patients were in the initial phaseExpand
  • 44
  • 3
Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in European families with phenylketonuria (PKU).
DNA haplotype data from the phenylalanine hydroxylase (PAH) locus are available from a number of European populations as a result of RFLP testing for genetic counseling in families withExpand
  • 54
  • 3
Guidelines for a therapeutic alliance between families and staff: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology.
This, the fifth official document of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology, develops another important topic: the Therapeutic Alliance between families and staff.Expand
  • 54
  • 3
SIOP Working Committee on Psychosocial issues in pediatric oncology: guidelines for care of long-term survivors.
This is the third official document of the SIOP Working Committee on Psychosocial issues in pediatric oncology constituted in 1991. This document develops another topic already discussed and approvedExpand
  • 36
  • 2
The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia
Between 1971 and 1981, 699 children were diagnosed to have acute lymphoblastic leukemia (ALL) in Hungary. 34 of these children had received prednisolone therapy prior to the establishment of theExpand
  • 48
  • 2
Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemia.
Apoptosis (programmed cell death) is a physiologic phenomenon wherein the dying cell plays an active part in its own destruction. It has an important role in regulation of the balance of cellExpand
  • 23
  • 2
Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours.
This prospective, randomised pilot study was designed to evaluate safety, feasibility and efficacy of recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-inducedExpand
  • 26
  • 2
...
1
2
3
4
5
...